Skip to main content

Table 1 Clinical data

From: Clinical significance of red blood cell distribution width in systemic lupus erythematosus patients

Characteristics

 

Active SLE

Inactive

p value

Duration of disease

2.72 ± 1.42

5.45 ± 2.26

0.001(HS)

Malar rash

Current

16 (53.3%)

8 (26.7%)

0.001 (HS)

History

12 (40%)

14 (46.6%)

Negative

2 (6.7%)

8 (26.7%)

DLE

Current

1 (3.3%)

1 (3.3%)

0.21(NS)

History

2(6.6%)

3 (10%)

Negative

27(90.1%)

26 (86.7%)

Photosensitivity

Current

20 (66.7%)

6 (20%)

0.001 (HS)

History

10 (33.3%)

19 (63.3%)

Negative

0 (0%)

5 (16.7%)

Oral ulcers

Current

12 (40%)

11 (36.7%)

0.001 (HS)

History

17 (56.7%)

10 (33.3%)

Negative

1 (3.3%)

9 (30%)

Alopecia

Current

11 (36.7%)

5 (16.7%)

0.001 (HS)

History

17 (56.7%)

14 (46.6%)

Negative

2 (6.6%)

11 (36.7%)

Serositis

Current

5 (16.7%)

2 (6.7%)

0.005 (S)

History

8 (26.6%)

6 (20%)

Negative

17 (56.7%)

22 (73.3%)

Neuropsychiatric

Current

3 (10%)

1 (3.3%)

0.005 (S)

History

5 (16.7%)

2 (6.6%)

Negative

22 (73.3%)

27 (90.1%)

Lupus nephritis

Current

27 (90%)

9 (30%)

0.001 (HS)

History

3 (10%)

15 (50%)

Negative

0 (0%(

6 (20%(

Arthritis

Current

20 (66.7%)

5 (16.7%)

0.001 (HS)

History

6 (20%)

19 (63.3%)

Negative

4 (13.3%)

6 (20%)

  1. p value: (S) significant, (NS) non-significant, and (HS) highly significant
  2. DLE discoid lupus erythematosus